We offer only high-quality CBD products. Our CBD is organic, THC-free, has no pesticides and us grow by licenses U.S. farmers.
What do we know about CBD?
A study done by Brightfield Group and HelloMD states that CBD (Cannabidiol) is known for the medical relief it provides for a plethora of conditions without the psychoactive effects or "high" caused by THC. During this study, they found the top medical conditions treated by CBD were depression, insomnia, anxiety and joint pain. 42% of CBD users (in the study) stopped using traditional medications and used some form of cannabis instead and 80% of users found CBD products to be a very or extremely effective treatment. 90% of respondents would be likely to buy CBD products again. The most talked about benefit of CBD-Only products is relief and relaxation without the psychoactive effects from THC. According to study participants, there is a vast range of medical conditions that CBD seems to offer relief. These conditions include anxiety, insomnia or sleep problems, joint pain and inflammation, depression, muscle tension or strain, migraines or tension headaches, severe or chronic pain, arthritis, nausea, menstrual cramps, skin concerns, diabetes, ADHD, and stomach issues (IBS, loss of appetite, etc.).
Lawrence Taylor who during his 13-year career, was named an All-Pro six times (1981–1987) and made 10 Pro Bowl appearances (1981–1990 seasons) also has something to say about CBD. "Ever since I discovered CBD, it has become my preferred method of alleviating pain and relieving muscle soreness and inflammation."
Cannabidiol (CBD) is used by a number of people suffering from chronic pain, and that number is growing.
CBD oil may reduce pain, inflammation, and overall discomfort related to a variety of health conditions.
Interesting Facts about CBD
CBD does not produce euphoria or intoxication.
iii, iv, v
Promising research shows CBD could produce effects including, antioxidant, anti-inflammatory, and anti-anxiety properties. The result would help with a number of issues including join pain, depression, insomnia, and anxiety.
Recently studies have shown that CBD has an anti-seizure property, which has shown to help reduce the severity of seizures. vi,vii
A recent doubleblind trail in patients with Parkinson's disease found that CBD improved quality of life scores. xxii
For cancer patients, new studies are finding reduced cell viability, increased cancer cell death, decreased tumor growth and inhibition of metastasis. xxx
The medical director of the George Washington University Center of Integrative Medicine, Mikhail Kogan, was quoted in the Washington Post by David Kohn on December 31, 2016 to have said, "This is a really powerful compound. I've seen it work for a lot of my patients with illnesses such as epilepsy, post-traumatic stress disorder, anxiety, autoimmune disorders, autism and insomnia."
iii Martin-Santos et al. Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Des. 2012;18(32):4966-79.
iv Fusar-Poli et al. Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing. Arch Gen Psychiatry. 2009;66(1):95-105.
v Winton-Brown et al. Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study. Neuropsychopharmacology. 2011 Jun;36(7):1340-8.
vi Jones et al. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures. Seizure. 2012 Jun;21(5):344-52.
vii Consroe P and Wolkin A. Cannabidiol--antiepileptic drug comparisons and interactions in experimentally induced seizures in rats. J Pharmacol Exp Ther. 1977 Apr;201(1):26-32.
xxii Chagas et al. Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial. J Psychopharmacol. 28(11):1088-98. (2014).
xxx Massi et al. 5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. J Neurochem. 2008 Feb;104(4):1091-100.